nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—SULT1A1—Cytosolic sulfonation of small molecules—SLC26A1—nephrolithiasis	0.0368	0.188	CbGpPWpGaD
Tamoxifen—DHCR7—Vitamin D Metabolism—PTH—nephrolithiasis	0.0322	0.164	CbGpPWpGaD
Tamoxifen—Cutaneous vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0321	0.0757	CcSEcCtD
Tamoxifen—FMO3—urine—nephrolithiasis	0.0316	0.0876	CbGeAlD
Tamoxifen—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0181	0.0428	CcSEcCtD
Tamoxifen—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0403	CcSEcCtD
Tamoxifen—Diphemanil Methylsulfate—CHRM3—nephrolithiasis	0.0158	0.847	CrCbGaD
Tamoxifen—CYP2C19—urine—nephrolithiasis	0.014	0.0387	CbGeAlD
Tamoxifen—SULT1A1—renal system—nephrolithiasis	0.0126	0.0349	CbGeAlD
Tamoxifen—SULT1A1—kidney—nephrolithiasis	0.0122	0.0337	CbGeAlD
Tamoxifen—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0274	CcSEcCtD
Tamoxifen—CYP1A2—urine—nephrolithiasis	0.0114	0.0316	CbGeAlD
Tamoxifen—UGT1A4—renal system—nephrolithiasis	0.011	0.0304	CbGeAlD
Tamoxifen—CYP2C9—urine—nephrolithiasis	0.0108	0.03	CbGeAlD
Tamoxifen—UGT1A4—kidney—nephrolithiasis	0.0106	0.0294	CbGeAlD
Tamoxifen—CYP2E1—urine—nephrolithiasis	0.0103	0.0284	CbGeAlD
Tamoxifen—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0238	CcSEcCtD
Tamoxifen—DHCR7—nephron tubule—nephrolithiasis	0.00986	0.0273	CbGeAlD
Tamoxifen—FMO1—nephron tubule—nephrolithiasis	0.00986	0.0273	CbGeAlD
Tamoxifen—ESRRA—nephron tubule—nephrolithiasis	0.0097	0.0268	CbGeAlD
Tamoxifen—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00967	0.0228	CcSEcCtD
Tamoxifen—SULT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.0094	0.048	CbGpPWpGaD
Tamoxifen—FMO1—renal system—nephrolithiasis	0.00896	0.0248	CbGeAlD
Tamoxifen—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00886	0.0209	CcSEcCtD
Tamoxifen—ESRRA—renal system—nephrolithiasis	0.00882	0.0244	CbGeAlD
Tamoxifen—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0206	CcSEcCtD
Tamoxifen—FMO1—kidney—nephrolithiasis	0.00866	0.024	CbGeAlD
Tamoxifen—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00858	0.0202	CcSEcCtD
Tamoxifen—ESRRA—kidney—nephrolithiasis	0.00853	0.0236	CbGeAlD
Tamoxifen—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00848	0.02	CcSEcCtD
Tamoxifen—DHCR7—cortex of kidney—nephrolithiasis	0.00844	0.0233	CbGeAlD
Tamoxifen—FMO1—cortex of kidney—nephrolithiasis	0.00844	0.0233	CbGeAlD
Tamoxifen—ESRRA—cortex of kidney—nephrolithiasis	0.0083	0.023	CbGeAlD
Tamoxifen—CYP3A4—urine—nephrolithiasis	0.00827	0.0229	CbGeAlD
Tamoxifen—CYP2D6—urine—nephrolithiasis	0.00814	0.0225	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00716	0.0198	CbGeAlD
Tamoxifen—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00689	0.0163	CcSEcCtD
Tamoxifen—Injury—Hydrochlorothiazide—nephrolithiasis	0.00662	0.0156	CcSEcCtD
Tamoxifen—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0065	0.0153	CcSEcCtD
Tamoxifen—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0152	CcSEcCtD
Tamoxifen—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0151	CcSEcCtD
Tamoxifen—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00639	0.0151	CcSEcCtD
Tamoxifen—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00626	0.0148	CcSEcCtD
Tamoxifen—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00613	0.017	CbGeAlD
Tamoxifen—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00576	0.0136	CcSEcCtD
Tamoxifen—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0057	0.0134	CcSEcCtD
Tamoxifen—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00561	0.0132	CcSEcCtD
Tamoxifen—SULT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.0055	0.0281	CbGpPWpGaD
Tamoxifen—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00548	0.0129	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00548	0.0129	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00536	0.0126	CcSEcCtD
Tamoxifen—ESR2—renal system—nephrolithiasis	0.00529	0.0146	CbGeAlD
Tamoxifen—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00526	0.0124	CcSEcCtD
Tamoxifen—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00526	0.0124	CcSEcCtD
Tamoxifen—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00515	0.0121	CcSEcCtD
Tamoxifen—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00512	0.0121	CcSEcCtD
Tamoxifen—ESR2—kidney—nephrolithiasis	0.00512	0.0142	CbGeAlD
Tamoxifen—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0116	CcSEcCtD
Tamoxifen—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00484	0.0114	CcSEcCtD
Tamoxifen—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0113	CcSEcCtD
Tamoxifen—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.0111	CcSEcCtD
Tamoxifen—UGT1A4—Phase II conjugation—SLC26A1—nephrolithiasis	0.00468	0.0239	CbGpPWpGaD
Tamoxifen—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00465	0.011	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00462	0.0109	CcSEcCtD
Tamoxifen—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00459	0.0108	CcSEcCtD
Tamoxifen—FMO1—Biological oxidations—SLC26A1—nephrolithiasis	0.00457	0.0233	CbGpPWpGaD
Tamoxifen—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00455	0.0107	CcSEcCtD
Tamoxifen—SIGMAR1—nephron tubule—nephrolithiasis	0.00451	0.0125	CbGeAlD
Tamoxifen—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00449	0.0106	CcSEcCtD
Tamoxifen—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0104	CcSEcCtD
Tamoxifen—ABCC2—nephron tubule—nephrolithiasis	0.00438	0.0121	CbGeAlD
Tamoxifen—CYP1B1—nephron tubule—nephrolithiasis	0.00429	0.0119	CbGeAlD
Tamoxifen—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00992	CcSEcCtD
Tamoxifen—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00987	CcSEcCtD
Tamoxifen—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00417	0.00984	CcSEcCtD
Tamoxifen—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00414	0.00977	CcSEcCtD
Tamoxifen—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00956	CcSEcCtD
Tamoxifen—ABCC2—renal system—nephrolithiasis	0.00398	0.011	CbGeAlD
Tamoxifen—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00938	CcSEcCtD
Tamoxifen—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0092	CcSEcCtD
Tamoxifen—CYP1B1—renal system—nephrolithiasis	0.0039	0.0108	CbGeAlD
Tamoxifen—SIGMAR1—cortex of kidney—nephrolithiasis	0.00386	0.0107	CbGeAlD
Tamoxifen—ABCC2—kidney—nephrolithiasis	0.00385	0.0107	CbGeAlD
Tamoxifen—CES1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00384	0.0196	CbGpPWpGaD
Tamoxifen—CYP1B1—kidney—nephrolithiasis	0.00377	0.0104	CbGeAlD
Tamoxifen—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00376	0.00886	CcSEcCtD
Tamoxifen—ABCC2—cortex of kidney—nephrolithiasis	0.00375	0.0104	CbGeAlD
Tamoxifen—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00876	CcSEcCtD
Tamoxifen—CYP1B1—cortex of kidney—nephrolithiasis	0.00367	0.0102	CbGeAlD
Tamoxifen—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00366	0.00863	CcSEcCtD
Tamoxifen—ESR1—renal system—nephrolithiasis	0.00363	0.01	CbGeAlD
Tamoxifen—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.0036	0.0184	CbGpPWpGaD
Tamoxifen—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00845	CcSEcCtD
Tamoxifen—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00835	CcSEcCtD
Tamoxifen—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0083	CcSEcCtD
Tamoxifen—ESR1—kidney—nephrolithiasis	0.00351	0.0097	CbGeAlD
Tamoxifen—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00798	CcSEcCtD
Tamoxifen—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00789	CcSEcCtD
Tamoxifen—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00773	CcSEcCtD
Tamoxifen—FMO3—Biological oxidations—SLC26A1—nephrolithiasis	0.00327	0.0167	CbGpPWpGaD
Tamoxifen—Cough—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00753	CcSEcCtD
Tamoxifen—ABCG2—nephron tubule—nephrolithiasis	0.00319	0.00884	CbGeAlD
Tamoxifen—UGT1A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00312	0.0159	CbGpPWpGaD
Tamoxifen—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00735	CcSEcCtD
Tamoxifen—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00735	CcSEcCtD
Tamoxifen—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00735	CcSEcCtD
Tamoxifen—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00733	CcSEcCtD
Tamoxifen—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00726	CcSEcCtD
Tamoxifen—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00719	CcSEcCtD
Tamoxifen—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00705	CcSEcCtD
Tamoxifen—CYP2C8—renal system—nephrolithiasis	0.00299	0.00826	CbGeAlD
Tamoxifen—CYP3A5—nephron tubule—nephrolithiasis	0.00297	0.00821	CbGeAlD
Tamoxifen—CYP2B6—nephron tubule—nephrolithiasis	0.00295	0.00816	CbGeAlD
Tamoxifen—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0069	CcSEcCtD
Tamoxifen—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00681	CcSEcCtD
Tamoxifen—CYP2C8—kidney—nephrolithiasis	0.00289	0.00799	CbGeAlD
Tamoxifen—Promazine—CHRM3—nephrolithiasis	0.00286	0.153	CrCbGaD
Tamoxifen—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00672	CcSEcCtD
Tamoxifen—CYP1A2—renal system—nephrolithiasis	0.00279	0.00773	CbGeAlD
Tamoxifen—CYP2E1—nephron tubule—nephrolithiasis	0.00277	0.00765	CbGeAlD
Tamoxifen—CYP1A1—renal system—nephrolithiasis	0.00276	0.00763	CbGeAlD
Tamoxifen—UGT1A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00274	0.014	CbGpPWpGaD
Tamoxifen—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00642	CcSEcCtD
Tamoxifen—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00637	CcSEcCtD
Tamoxifen—CYP3A5—renal system—nephrolithiasis	0.0027	0.00746	CbGeAlD
Tamoxifen—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00268	0.00633	CcSEcCtD
Tamoxifen—CYP2B6—renal system—nephrolithiasis	0.00268	0.00741	CbGeAlD
Tamoxifen—CYP1A1—kidney—nephrolithiasis	0.00267	0.00738	CbGeAlD
Tamoxifen—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00628	CcSEcCtD
Tamoxifen—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0062	CcSEcCtD
Tamoxifen—CYP3A5—kidney—nephrolithiasis	0.00261	0.00721	CbGeAlD
Tamoxifen—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00613	CcSEcCtD
Tamoxifen—CYP2B6—kidney—nephrolithiasis	0.00259	0.00717	CbGeAlD
Tamoxifen—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00608	CcSEcCtD
Tamoxifen—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00603	CcSEcCtD
Tamoxifen—Pain—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00603	CcSEcCtD
Tamoxifen—CYP3A5—cortex of kidney—nephrolithiasis	0.00254	0.00702	CbGeAlD
Tamoxifen—CYP2E1—renal system—nephrolithiasis	0.00251	0.00696	CbGeAlD
Tamoxifen—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00244	0.00576	CcSEcCtD
Tamoxifen—CYP2E1—kidney—nephrolithiasis	0.00243	0.00673	CbGeAlD
Tamoxifen—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00237	0.0056	CcSEcCtD
Tamoxifen—CYP2E1—cortex of kidney—nephrolithiasis	0.00237	0.00655	CbGeAlD
Tamoxifen—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00557	CcSEcCtD
Tamoxifen—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00519	CcSEcCtD
Tamoxifen—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00506	CcSEcCtD
Tamoxifen—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00499	CcSEcCtD
Tamoxifen—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00482	CcSEcCtD
Tamoxifen—CYP3A4—renal system—nephrolithiasis	0.00202	0.0056	CbGeAlD
Tamoxifen—CYP2D6—renal system—nephrolithiasis	0.00199	0.00551	CbGeAlD
Tamoxifen—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00466	CcSEcCtD
Tamoxifen—CYP3A4—kidney—nephrolithiasis	0.00196	0.00541	CbGeAlD
Tamoxifen—CYP2D6—kidney—nephrolithiasis	0.00192	0.00533	CbGeAlD
Tamoxifen—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00448	CcSEcCtD
Tamoxifen—Rash—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00444	CcSEcCtD
Tamoxifen—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00444	CcSEcCtD
Tamoxifen—Headache—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00441	CcSEcCtD
Tamoxifen—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00419	CcSEcCtD
Tamoxifen—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00175	0.00893	CbGpPWpGaD
Tamoxifen—ABCB1—nephron tubule—nephrolithiasis	0.00158	0.00436	CbGeAlD
Tamoxifen—CYP19A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00152	0.00777	CbGpPWpGaD
Tamoxifen—CYP1B1—Biological oxidations—SLC26A1—nephrolithiasis	0.00147	0.00748	CbGpPWpGaD
Tamoxifen—ABCB1—renal system—nephrolithiasis	0.00143	0.00396	CbGeAlD
Tamoxifen—ABCB1—kidney—nephrolithiasis	0.00138	0.00383	CbGeAlD
Tamoxifen—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00138	0.00705	CbGpPWpGaD
Tamoxifen—ABCB1—cortex of kidney—nephrolithiasis	0.00135	0.00373	CbGeAlD
Tamoxifen—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00132	0.00675	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GRHPR—nephrolithiasis	0.00126	0.00646	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GRHPR—nephrolithiasis	0.00124	0.00634	CbGpPWpGaD
Tamoxifen—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00121	0.00619	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GRHPR—nephrolithiasis	0.0012	0.00612	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—AGXT—nephrolithiasis	0.00113	0.00575	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—AGXT—nephrolithiasis	0.00111	0.00565	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—AGXT—nephrolithiasis	0.00107	0.00546	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GRHPR—nephrolithiasis	0.00103	0.00526	CbGpPWpGaD
Tamoxifen—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000984	0.00502	CbGpPWpGaD
Tamoxifen—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.000977	0.00499	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000975	0.00498	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000975	0.00498	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GRHPR—nephrolithiasis	0.000958	0.00489	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—APRT—nephrolithiasis	0.000958	0.00489	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—SLC26A1—nephrolithiasis	0.000958	0.00489	CbGpPWpGaD
Tamoxifen—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000957	0.00489	CbGpPWpGaD
Tamoxifen—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.000955	0.00488	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—APRT—nephrolithiasis	0.00094	0.0048	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—SLC26A1—nephrolithiasis	0.00094	0.0048	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—AGXT—nephrolithiasis	0.000919	0.00469	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—APRT—nephrolithiasis	0.000908	0.00464	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—SLC26A1—nephrolithiasis	0.000908	0.00464	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000903	0.00461	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000869	0.00444	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—AGXT—nephrolithiasis	0.000854	0.00436	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000848	0.00433	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000848	0.00433	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000827	0.00423	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000795	0.00406	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000795	0.00406	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—APRT—nephrolithiasis	0.000781	0.00399	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—SLC26A1—nephrolithiasis	0.000781	0.00399	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000756	0.00386	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000739	0.00377	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GRHPR—nephrolithiasis	0.000737	0.00376	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—APRT—nephrolithiasis	0.000726	0.00371	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—SLC26A1—nephrolithiasis	0.000726	0.00371	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000691	0.00353	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000691	0.00353	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—AQP1—nephrolithiasis	0.000683	0.00349	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000679	0.00347	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000673	0.00344	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—AQP1—nephrolithiasis	0.00067	0.00342	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AGXT—nephrolithiasis	0.000657	0.00335	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—AQP1—nephrolithiasis	0.000647	0.00331	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CHRM3—nephrolithiasis	0.000617	0.00315	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GRHPR—nephrolithiasis	0.000617	0.00315	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CHRM3—nephrolithiasis	0.000606	0.00309	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000602	0.00308	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000602	0.00308	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CHRM3—nephrolithiasis	0.000585	0.00299	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000576	0.00294	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00056	0.00286	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00056	0.00286	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—SLC26A1—nephrolithiasis	0.000558	0.00285	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—APRT—nephrolithiasis	0.000558	0.00285	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—AQP1—nephrolithiasis	0.000557	0.00284	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AGXT—nephrolithiasis	0.00055	0.00281	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000524	0.00267	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000524	0.00267	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—AQP1—nephrolithiasis	0.000517	0.00264	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CHRM3—nephrolithiasis	0.000503	0.00257	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000499	0.00255	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000499	0.00255	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000487	0.00249	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000487	0.00249	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CHRM3—nephrolithiasis	0.000468	0.00239	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—APRT—nephrolithiasis	0.000468	0.00239	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—SLC26A1—nephrolithiasis	0.000468	0.00239	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000458	0.00234	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000458	0.00234	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GRHPR—nephrolithiasis	0.000455	0.00232	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000444	0.00227	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000434	0.00222	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000434	0.00222	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000408	0.00209	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AGXT—nephrolithiasis	0.000406	0.00207	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000399	0.00204	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AQP1—nephrolithiasis	0.000398	0.00203	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000374	0.00191	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000374	0.00191	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CHRM3—nephrolithiasis	0.00036	0.00184	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000347	0.00177	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—SLC26A1—nephrolithiasis	0.000345	0.00176	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—APRT—nephrolithiasis	0.000345	0.00176	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GRHPR—nephrolithiasis	0.000343	0.00175	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AQP1—nephrolithiasis	0.000333	0.0017	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GRHPR—nephrolithiasis	0.000331	0.00169	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AGXT—nephrolithiasis	0.000306	0.00156	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ADCY10—nephrolithiasis	0.000302	0.00154	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CHRM3—nephrolithiasis	0.000302	0.00154	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000301	0.00154	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000298	0.00152	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AGXT—nephrolithiasis	0.000295	0.00151	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000283	0.00145	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000283	0.00145	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000273	0.0014	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000268	0.00137	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000266	0.00136	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000263	0.00134	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000263	0.00134	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—SLC26A1—nephrolithiasis	0.00026	0.00133	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—APRT—nephrolithiasis	0.00026	0.00133	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RGS14—nephrolithiasis	0.000257	0.00131	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	0.000251	0.00128	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—APRT—nephrolithiasis	0.000251	0.00128	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AQP1—nephrolithiasis	0.000246	0.00126	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000244	0.00124	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000235	0.0012	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000235	0.0012	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000228	0.00116	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APRT—nephrolithiasis	0.000228	0.00116	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000226	0.00115	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000226	0.00115	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CHRM3—nephrolithiasis	0.000222	0.00114	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000221	0.00113	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000216	0.0011	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000216	0.0011	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000207	0.00106	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000207	0.00106	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000204	0.00104	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000197	0.001	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000193	0.000983	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000192	0.000981	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000188	0.000958	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000187	0.000954	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AQP1—nephrolithiasis	0.000185	0.000947	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000182	0.000927	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AQP1—nephrolithiasis	0.000179	0.000912	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DGKH—nephrolithiasis	0.000174	0.000887	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000174	0.000887	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CHRM3—nephrolithiasis	0.000168	0.000857	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000167	0.000854	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000167	0.000854	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000167	0.000851	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000166	0.00085	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000164	0.000836	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000164	0.000836	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000163	0.000834	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000163	0.000834	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000163	0.000831	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000162	0.00083	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CHRM3—nephrolithiasis	0.000162	0.000825	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000161	0.000822	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000154	0.000788	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000154	0.000788	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000153	0.000783	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000152	0.000776	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000149	0.000759	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000148	0.000754	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000147	0.00075	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000146	0.000744	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000145	0.00074	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000142	0.000723	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000142	0.000723	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000137	0.000698	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000135	0.000692	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.000133	0.000682	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.00013	0.000663	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000126	0.000645	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000126	0.000645	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000126	0.000641	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APRT—nephrolithiasis	0.000123	0.00063	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000123	0.00063	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000119	0.000608	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000117	0.000596	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000116	0.000594	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000116	0.000593	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000116	0.000593	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000116	0.000591	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000115	0.000588	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000115	0.000588	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTH—nephrolithiasis	0.000115	0.000586	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.00011	0.000562	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000108	0.00055	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CHRM3—nephrolithiasis	0.000105	0.000539	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000105	0.000538	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000101	0.000515	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.0001	0.000512	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CHRM3—nephrolithiasis	9.95e-05	0.000508	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	9.84e-05	0.000503	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APRT—nephrolithiasis	9.84e-05	0.000503	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CHRM3—nephrolithiasis	9.12e-05	0.000466	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AQP1—nephrolithiasis	9e-05	0.00046	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AGXT—nephrolithiasis	8.93e-05	0.000456	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AQP1—nephrolithiasis	8.78e-05	0.000449	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AQP1—nephrolithiasis	8.28e-05	0.000423	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AQP1—nephrolithiasis	8.21e-05	0.000419	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CHRM3—nephrolithiasis	8.14e-05	0.000416	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CHRM3—nephrolithiasis	7.94e-05	0.000406	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APRT—nephrolithiasis	7.6e-05	0.000388	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	7.6e-05	0.000388	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CHRM3—nephrolithiasis	7.49e-05	0.000382	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CHRM3—nephrolithiasis	7.42e-05	0.000379	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AQP1—nephrolithiasis	7.01e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CHRM3—nephrolithiasis	6.34e-05	0.000324	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SPP1—nephrolithiasis	5.76e-05	0.000294	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AQP1—nephrolithiasis	5.41e-05	0.000276	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.89e-05	0.00025	CbGpPWpGaD
